All News

A large insurance database study found that more than 80% of pregnant patients with depression or anxiety discontinued SSRI/SNRI therapy, which was associated with nearly double the rate of mental health emergencies compared to those who continued treatment.

Sara Perelmuter details how naming Genitourinary Syndrome of Lactation (GSL) is a vital step in addressing the treatment gap in postpartum care.

According to FLO Living, the Cycle Syncing Method resulted in 92% of participants reporting meaningful reductions in the number and intensity of PMS symptoms after 60 days.

Alessandro Santin, MD, highlights how POLE and mismatch repair mutations in high-grade ESS create a clinical opportunity for using immune checkpoint inhibitors.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

New research from the COEQUaL initiative is examining how clinical counseling, insurance design, and referral patterns shape disparities in uterine fibroid care.

Julia Ordway highlights a case where unregulated testosterone pellets led to a 2-year recovery period.

"It's only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets," said study investigator Alessandro Santin, MD.

Standardized, patient-completed screening for substance use at delivery admissions reduced racial disparities in urine toxicology testing while improving testing efficiency, according a study from Mariam Naqvi, MD, and colleagues.

Research indicates that LMWH prophylaxis effectively mitigates the high risk of pregnancy loss and reduced natural fecundity associated with protein S deficiency.

An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.

The Menopause Society reported new data from 68 health organizations that showed vaginal estrogen therapy does not elevate recurrence risk in survivors aged 18 to 51.

Dardik explains how De Novo-cleared AI identifies preterm birth risk in low-risk pregnancies through whole-image analysis.

In a 29-state review of 2017–2019 data, 86.4% of pregnancy-related infection deaths were deemed preventable, with genital tract infections, group A streptococcus, and delays in antibiotics emerging as key targets for intervention.

Kevin Benson highlighted that the TITAN 2 study demonstrates the Altaviva ITNM system as a safe, minimally invasive, and durable solution for real-world patients who have failed prior overactive bladder treatments.

Results from the TITAN 2 study presented at SUFU 2026 demonstrate that the Altaviva ITNM system provides sustained reduction in UUI episodes and improved quality of life through 24 months.

Data published in npj Digital Medicine indicates that digital symptom checkers for endometriosis can reduce diagnostic delay by over 4 years and save more than $5,000 per patient.

Raquel Dardik explains how the FDA-cleared Delivery Date AI uses unbiased image analysis to provide a precise predicted delivery date without disrupting existing clinical workflows.

The FDA has cleared a cloud-based AI tool that predicts delivery dates solely from ultrasound images.

Research published in The BMJ indicates that individuals vaccinated against HPV before age 17 experience a 79% reduction in invasive cervical cancer risk compared to unvaccinated peers.

Sean Raj, MD, MBA, emphasizes that ob-gyns are uniquely positioned to improve cardiovascular outcomes by integrating risk assessments and imaging-based screenings into routine women's health visits.

A Finnish registry study indicates that women with endometriosis have a 51% higher risk of miscarriage and a 2-fold increased risk of ectopic pregnancy compared to controls.

Researchers reported that lidocaine did not affect POUR rates but enhanced early recovery metrics after SUI surgery.

A global analysis found significant disparities in magnesium sulfate use for preterm birth, particularly between higher- and middle-income countries.

A prospective observational study found that age did not independently affect bone mineral density response to romosozumab in postmenopausal women.

Sasha Vereecken explains the potential quality of life and sexual worry benefits of investigational ACT for stress urinary incontinence, as well as who may be best suited for the implant.

Very early home pregnancy testing modestly advances detection but substantially increases false negatives and detection of very early pregnancy losses, according to a recent study.

A large-scale TriNetX database analysis found no statistically significant difference in the incidence of vulvar atrophy or hypertrophy between non-diabetic women using GLP-1RAs and those who were not.